The Ensign Group, Inc. (NASDAQ:ENSG) had its price target boosted by Cantor Fitzgerald from $23.00 to $27.00 in a research report sent to investors on Thursday, November 9th. They currently have an overweight rating on the stock.
“Adjusting outlook. We are trimming our 2017 EPS estimate to $1.42 from $1.45, but are raising our 2018 estimate to $1.65 from $1.60 to reflect stronger recent revenue growth in ENSG’s core skilled nursing business, as well as its ancillary businesses.”,” the firm’s analyst commented.
Several other research firms also recently issued reports on ENSG. Royal Bank Of Canada reiterated a buy rating and issued a $21.00 price objective on shares of The Ensign Group in a report on Tuesday, November 7th. BidaskClub downgraded The Ensign Group from a strong-buy rating to a buy rating in a report on Monday, July 31st. TheStreet upgraded The Ensign Group from a c+ rating to a b rating in a report on Monday, August 7th. Finally, Zacks Investment Research downgraded The Ensign Group from a hold rating to a sell rating in a report on Tuesday, August 8th. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company. The Ensign Group has a consensus rating of Hold and a consensus price target of $24.50.
Shares of The Ensign Group (NASDAQ:ENSG) opened at $24.08 on Thursday. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $1,227.58, a price-to-earnings ratio of 20.33 and a beta of 0.84. The Ensign Group has a 1 year low of $16.50 and a 1 year high of $24.34.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, October 31st. Stockholders of record on Saturday, September 30th were given a dividend of $0.043 per share. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.17 annualized dividend and a dividend yield of 0.71%. The Ensign Group’s dividend payout ratio is currently 18.89%.
In other news, Director Antoinette T. Hubenette sold 2,500 shares of the business’s stock in a transaction dated Tuesday, September 12th. The stock was sold at an average price of $20.95, for a total value of $52,375.00. Following the completion of the sale, the director now directly owns 24,626 shares of the company’s stock, valued at approximately $515,914.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last ninety days, insiders have sold 3,566 shares of company stock valued at $75,957. Insiders own 6.20% of the company’s stock.
A number of institutional investors have recently added to or reduced their stakes in the stock. Wasatch Advisors Inc. raised its position in shares of The Ensign Group by 2.6% in the 2nd quarter. Wasatch Advisors Inc. now owns 6,589,769 shares of the company’s stock valued at $143,459,000 after buying an additional 170,072 shares in the last quarter. BlackRock Inc. raised its position in shares of The Ensign Group by 0.3% in the 2nd quarter. BlackRock Inc. now owns 5,951,320 shares of the company’s stock worth $129,561,000 after purchasing an additional 19,967 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of The Ensign Group by 2.3% during the 2nd quarter. Vanguard Group Inc. now owns 4,475,647 shares of the company’s stock valued at $97,435,000 after acquiring an additional 102,129 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of The Ensign Group by 2.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,234,334 shares of the company’s stock worth $50,474,000 after acquiring an additional 47,217 shares in the last quarter. Finally, State Street Corp raised its holdings in shares of The Ensign Group by 5.5% during the 2nd quarter. State Street Corp now owns 1,289,881 shares of the company’s stock worth $28,076,000 after acquiring an additional 67,741 shares in the last quarter. 84.57% of the stock is owned by institutional investors and hedge funds.
About The Ensign Group
The Ensign Group, Inc, through its operating subsidiaries, provides healthcare services across the post-acute care continuum, as well as other ancillary businesses located in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Texas, Utah, Washington and Wisconsin.
Receive News & Ratings for The Ensign Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group Inc. and related companies with our FREE daily email newsletter.